These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26480202)

  • 1. Perturbation of the transcriptome: implications of the innate immune system in Alzheimer's disease.
    Song F; Qian Y; Peng X; Han G; Wang J; Bai Z; Crack PJ; Lei H
    Curr Opin Pharmacol; 2016 Feb; 26():47-53. PubMed ID: 26480202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TREM2, Microglia, and Neurodegenerative Diseases.
    Yeh FL; Hansen DV; Sheng M
    Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TREM2 regulates innate immunity in Alzheimer's disease.
    Li JT; Zhang Y
    J Neuroinflammation; 2018 Apr; 15(1):107. PubMed ID: 29655369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TREM2 and the neuroimmunology of Alzheimer's disease.
    Hickman SE; El Khoury J
    Biochem Pharmacol; 2014 Apr; 88(4):495-8. PubMed ID: 24355566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TREM2 analysis and increased risk of Alzheimer's disease.
    Finelli D; Rollinson S; Harris J; Jones M; Richardson A; Gerhard A; Snowden J; Mann D; Pickering-Brown S
    Neurobiol Aging; 2015 Jan; 36(1):546.e9-13. PubMed ID: 25260849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of innate immune genes in Alzheimer's disease.
    Griciuc A; Tanzi RE
    Curr Opin Neurol; 2021 Apr; 34(2):228-236. PubMed ID: 33560670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation in Alzheimer's Disease and Molecular Genetics: Recent Update.
    Zhang ZG; Li Y; Ng CT; Song YQ
    Arch Immunol Ther Exp (Warsz); 2015 Oct; 63(5):333-44. PubMed ID: 26232392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics and mechanistic elucidation of Alzheimer's disease risk genes in the brain and in vitro models.
    Martiskainen H; Viswanathan J; Nykänen NP; Kurki M; Helisalmi S; Natunen T; Sarajärvi T; Kurkinen KM; Pursiheimo JP; Rauramaa T; Alafuzoff I; Jääskeläinen JE; Leinonen V; Soininen H; Haapasalo A; Huttunen HJ; Hiltunen M
    Neurobiol Aging; 2015 Feb; 36(2):1221.e15-28. PubMed ID: 25281018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: Innate immunity gone awry?
    VanItallie TB
    Metabolism; 2017 Apr; 69S():S41-S49. PubMed ID: 28129888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TREM2 variants: new keys to decipher Alzheimer disease pathogenesis.
    Colonna M; Wang Y
    Nat Rev Neurosci; 2016 Apr; 17(4):201-7. PubMed ID: 26911435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease.
    Lewcock JW; Schlepckow K; Di Paolo G; Tahirovic S; Monroe KM; Haass C
    Neuron; 2020 Dec; 108(5):801-821. PubMed ID: 33096024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microglia heterogeneity and neurodegeneration: The emerging paradigm of the role of immunity in Alzheimer's disease.
    Hashemiaghdam A; Mroczek M
    J Neuroimmunol; 2020 Apr; 341():577185. PubMed ID: 32045774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidating the Role of TREM2 in Alzheimer's Disease.
    Ulrich JD; Ulland TK; Colonna M; Holtzman DM
    Neuron; 2017 Apr; 94(2):237-248. PubMed ID: 28426958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targets in Innate Immunity to Tackle Alzheimer's Disease.
    Serradas ML; Ding Y; Martorell PV; Kulińska I; Castro-Gomez S
    Cells; 2024 Aug; 13(17):. PubMed ID: 39272998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREMs in Alzheimer's disease: Genetic and clinical investigations.
    Cheng J; Guo X; Zhang T; Zhong L; Bu G; Chen X
    Clin Chim Acta; 2016 Dec; 463():88-95. PubMed ID: 27769848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What happens to microglial TREM2 in Alzheimer's disease: Immunoregulatory turned into immunopathogenic?
    Lue LF; Schmitz C; Walker DG
    Neuroscience; 2015 Aug; 302():138-50. PubMed ID: 25281879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Unique Microglia Type Associated with Restricting Development of Alzheimer's Disease.
    Keren-Shaul H; Spinrad A; Weiner A; Matcovitch-Natan O; Dvir-Szternfeld R; Ulland TK; David E; Baruch K; Lara-Astaiso D; Toth B; Itzkovitz S; Colonna M; Schwartz M; Amit I
    Cell; 2017 Jun; 169(7):1276-1290.e17. PubMed ID: 28602351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM2 upregulation correlates with 5-hydroxymethycytosine enrichment in Alzheimer's disease hippocampus.
    Celarain N; Sánchez-Ruiz de Gordoa J; Zelaya MV; Roldán M; Larumbe R; Pulido L; Echavarri C; Mendioroz M
    Clin Epigenetics; 2016; 8():37. PubMed ID: 27051467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of TREM2 in peripheral blood of Alzheimer's disease patients.
    Hu N; Tan MS; Yu JT; Sun L; Tan L; Wang YL; Jiang T; Tan L
    J Alzheimers Dis; 2014; 38(3):497-501. PubMed ID: 24002183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets.
    Nizami S; Hall-Roberts H; Warrier S; Cowley SA; Di Daniel E
    Br J Pharmacol; 2019 Sep; 176(18):3515-3532. PubMed ID: 30740661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.